Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 1
2013 2
2014 1
2015 3
2016 1
2017 5
2018 3
2019 2
2020 4
2021 7
2022 6
2023 3
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Results by year

Filters applied: . Clear all
Page 1
Clinical Efficacy and Metabolomics Modifications Induced by Polyphenol Compound Supplementation in the Treatment of Residual Dizziness following Semont Maneuver in Benign Paroxysmal Positional Vertigo (BPPV) of the Posterior Semicircular Canal (PSC): Preliminary Results.
Casani AP, Albera R, Piras C, Albera A, Noto A, Ducci N, Atzori L, Lucisano S, Mussap M, Fanos V. Casani AP, et al. Among authors: piras c. Metabolites. 2024 Jan 25;14(2):86. doi: 10.3390/metabo14020086. Metabolites. 2024. PMID: 38392978 Free PMC article.
Contemporary lipid-lowering management and risk of cardiovascular events in homozygous familial hypercholesterolaemia: insights from the Italian LIPIGEN Registry.
D'Erasmo L, Bini S, Casula M, Gazzotti M, Bertolini S, Calandra S, Tarugi P, Averna M, Iannuzzo G, Fortunato G, Catapano AL, Arca M; LIPIGEN HoFH group. D'Erasmo L, et al. Eur J Prev Cardiol. 2024 Feb 20:zwae036. doi: 10.1093/eurjpc/zwae036. Online ahead of print. Eur J Prev Cardiol. 2024. PMID: 38374534
Humoral responses to wild type and ancient BA.1 SARS-CoV-2 variant after heterologous priming vaccination with ChAdOx1 nCoV-19 and BNT162b2 booster dose.
Sanna G, Marongiu A, Firinu D, Piras C, Palmas V, Galdiero M, Atzori L, Caria P, Campagna M, Perra A, Costanzo G, Coghe F, Littera R, Chessa L, Manzin A. Sanna G, et al. Among authors: piras c. Clin Exp Med. 2024 Jan 20;24(1):12. doi: 10.1007/s10238-023-01276-x. Clin Exp Med. 2024. PMID: 38244064 Free PMC article.
Metabolomics in Otorhinolaryngology.
Noto A, Piras C, Atzori L, Mussap M, Albera A, Albera R, Casani AP, Capobianco S, Fanos V. Noto A, et al. Among authors: piras c. Front Mol Biosci. 2022 Sep 8;9:934311. doi: 10.3389/fmolb.2022.934311. eCollection 2022. Front Mol Biosci. 2022. PMID: 36158568 Free PMC article. Review.
Neutralizing Antibodies Responses against SARS-CoV-2 in a Sardinian Cohort Group Up to 9 Months after BNT162b2 Vaccination.
Sanna G, Marongiu A, Firinu D, Piras C, Franci G, Galdiero M, Pala G, Palmas V, Angius F, Littera R, Perra A, Orrù G, Campagna M, Costanzo G, Meloni F, Coghe F, Chessa L, Manzin A. Sanna G, et al. Among authors: piras c. Vaccines (Basel). 2022 Mar 29;10(4):531. doi: 10.3390/vaccines10040531. Vaccines (Basel). 2022. PMID: 35455280 Free PMC article.
41 results